Skip to content
TrustList
BioRock Ventures logo
Venture capital firm

BioRock Ventures

A seed-stage venture fund investing in life science companies developing new therapeutic drugs

  • Medical
BioRock Ventures cover

TrustList summary

BioRock Ventures is a seed-stage venture capital fund that invests in private life science companies developing novel, FDA-regulated therapeutic drugs, across all disease areas, stages and therapeutic modalities, from angel and seed rounds through Series A and later financings including pre-IPO and M&A situations. The fund is led by founding managing partner Mary Wheeler, based in the Bay Area, California, who spent two decades in operating roles, including as a therapeutics startup founder in Boston and in business and technical evaluation roles for mergers, acquisitions and licensing at larger pharmaceutical companies. She began venture investing roughly a decade ago and helped form two companies that each later completed initial public offerings.

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

  • Medical

Ask TrustList to introduce you to BioRock Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of BioRock Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about BioRock Ventures.

BioRock Ventures alternatives

Similar listings buyers compare against this one.

Venture firm investing in software and hardware startups for architecture, engineering and construction

Heidelberg-based investor in European life science, therapeutics and medical technology companies

US venture firm investing in early-stage medical technology and life sciences companies

Life sciences investment arm of Blackstone funding pharmaceutical, biotech and medical technology companies

US mezzanine and private equity investor financing privately owned middle-market companies across several industries

Inter-university venture fund turning research breakthroughs from Belgian institutes into new companies

Private equity investor for UK and European healthcare and life sciences small and medium-sized companies

Investment firm partnering with venture and growth funds to gain exposure to Chinese companies